BIOMAT Database Logo BIOMAT Database Logo

Muscle allograft survival after cyclosporin A immunosuppression. 1982

A K Gulati, and A A Zalewski

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008297 Male Males
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014182 Transplantation, Autologous Transplantation of an individual's own tissue from one site to another site. Autografting,Autologous Transplantation,Autotransplantation,Autograftings,Autologous Transplantations,Autotransplantations,Transplantations, Autologous
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic

Related Publications

A K Gulati, and A A Zalewski
Cyclosporin immunosuppression of sheep: pharmacokinetics and allograft survival.
August 2001, Veterinary immunology and immunopathology,
A K Gulati, and A A Zalewski
Short-course cyclosporin A therapy for definite allograft valve survival immunosuppression in allograft valve operations.
August 1995, The Annals of thoracic surgery,
A K Gulati, and A A Zalewski
Meshed allograft skin and cyclosporin immunosuppression.
September 1989, British journal of plastic surgery,
A K Gulati, and A A Zalewski
Prolongation of allograft survival by cyclosporin A.
January 1979, Surgical forum,
A K Gulati, and A A Zalewski
Cyclosporin treatment with conversion after three months versus conventional immunosuppression in renal allograft recipients.
March 1987, Lancet (London, England),
A K Gulati, and A A Zalewski
Renal allograft survival after 1 and 10 years: comparison between pre-cyclosporin and cyclosporin data.
January 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
A K Gulati, and A A Zalewski
Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment.
June 1978, Lancet (London, England),
A K Gulati, and A A Zalewski
Early renal allograft rejection episodes are less aggressive with cyclosporin-A immunosuppression.
December 1983, Transplantation proceedings,
A K Gulati, and A A Zalewski
Cardiac-allograft survival in primates treated with cyclosporin A.
March 1979, Lancet (London, England),
A K Gulati, and A A Zalewski
Persistent nonspecific immunosuppression after a course of cyclosporin A.
April 1980, Transplantation,
Copied contents to your clipboard!